MARYBETH MOORE: Open Payments
NPI 1033389192 · WEST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 22 payments from 11 companies in 2025. Trend: 2023 $1,415 · 2024 $630 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $283 |
| Tandem Diabetes Care, Inc. | 2 | $166 |
| Novo Nordisk Inc | 2 | $153 |
| Sequel Med Tech, LLC | 2 | $96 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Amgen Inc. | 2 | $48 |
| Dexcom, Inc. | 2 | $43 |
| Medtronic, Inc. | 1 | $32 |
| Insulet Corporation | 1 | $29 |
| Corcept Therapeutics | 1 | $19 |
Products named: FREESTYLE LIBRE 3, t:slim X2 Insulin Pump with Control-IQ, Ozempic, TWIIST, LEQVIO, Dexcom G6 Transmitter, MINIMED 780G, Omnipod.
Industry payments across CT — which companies pay providers there.
